Cargando…

Ability of the MeltPro MTB/PZA Assay to Detect Susceptibility to Pyrazinamide in Rifampin-Resistant Tuberculosis Patients

Prediction of susceptibility to pyrazinamide (PZA) directly from sputum has been challenging. The MeltPro MTB/PZA assay, based on melting curve analysis, can simultaneously detect Mycobacterium tuberculosis and the resistance to PZA from sputum. We aimed to evaluate the MeltPro MTB/PZA assay to pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rong, Li, Yang, Chen, Xinchang, Jia, Lina, Yu, Hongying, Huang, Ya, Wu, Qianhong, Xiao, Mingying, Ge, Shijia, Zhang, Yilin, Feng, Zhen, Li, Qingge, Xu, Ye, Shi, Wenzhi, Sun, Feng, Zhang, Wenhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269598/ https://www.ncbi.nlm.nih.gov/pubmed/37162355 http://dx.doi.org/10.1128/spectrum.04836-22

Ejemplares similares

Direct Determination of Pyrazinamide (PZA) Susceptibility by Sputum Microscopic Observation Drug Susceptibility (MODS) Culture at Neutral pH: the MODS-PZA Assay
por: Alcántara, Roberto, et al.
Publicado: (2020)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Activity of Pyrazinamide against Mycobacterium tuberculosis at Neutral pH in PZA-S1 Minimal Medium
por: Shi, Wanliang
Publicado: (2021)

Evaluation of the MeltPro Myco Assay for the Identification of Non-Tuberculous Mycobacteria
por: Lin, Jian, et al.
Publicado: (2022)

The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
por: Millard, James D., et al.
Publicado: (2019)

Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection
por: Liu, Zhi-bin, et al.
Publicado: (2023)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide
por: Kim, Joo-Hee, et al.
Publicado: (2010)

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana
por: Modongo, Chawangwa, et al.
Publicado: (2023)

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
por: Rockwood, Neesha, et al.
Publicado: (2016)

Simultaneous Determination of Isoniazid, Pyrazinamide and Rifampin in Human Plasma by High-performance Liquid Chromatography and UV Detection
por: Dasht Bozorg, Behnam, et al.
Publicado: (2019)

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score
por: Chen, Zongxin, et al.
Publicado: (2023)

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
por: Shi, Wanliang, et al.
Publicado: (2014)

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
por: Li, Kun, et al.
Publicado: (2021)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial
por: Feng, Zhen, et al.
Publicado: (2023)

A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting
por: Andres, Söenke, et al.
Publicado: (2019)

Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library
por: Niu, Hongxia, et al.
Publicado: (2017)

GeneXpert MTB/RIF Version G4 for Identification of Rifampin-Resistant Tuberculosis in a Programmatic Setting
por: Osman, Muhammad, et al.
Publicado: (2014)

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2013)

Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
por: Weng, Taoping, et al.
Publicado: (2021)

Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting
por: Rice, Jason P., et al.
Publicado: (2017)

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
por: Chakravorty, Soumitesh, et al.
Publicado: (2017)

Pyrazinamide induced thrombocytopenia
por: Kant, Surya, et al.
Publicado: (2010)

Dependence of Xpert MTB/RIF Accuracy for Detecting Rifampin Resistance in Bronchoalveolar Lavage Fluid on Bacterial Load: A Retrospective Study in Beijing, China
por: Qin, Lin, et al.
Publicado: (2021)

Multicolor Melting Curve Analysis-Based Multilocus Melt Typing of Vibrio parahaemolyticus
por: Liu, Ran, et al.
Publicado: (2015)

PYRAZINAMIDE-INDUCED MACULOPAPULAR RASH
por: Khayyam, Khalid Umer, et al.
Publicado: (2010)

Etymologia: Rifampin
por: Henry, Ronnie
Publicado: (2018)

Utility of the GeneXpert Mycobacterium tuberculosis/Rifampin (MTB/RIF) Assay on Paraffin-Embedded Biopsy Tissue Samples for Detecting Tuberculosis: Comparison With Histopathology
por: Hashmi, Atif A, et al.
Publicado: (2020)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
por: Sirous, Mehrandokht, et al.
Publicado: (2018)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice
por: Almeida, Deepak V., et al.
Publicado: (2014)

Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2017)

The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
por: Sun, Qingan, et al.
Publicado: (2020)

Calcitriol enhances pyrazinamide treatment of murine tuberculosis
por: Zhang, Jing, et al.
Publicado: (2019)

Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)
por: Meng, Ruijie, et al.
Publicado: (2022)

Multiplex Fluorescence Melting Curve Analysis for Mutation Detection with Dual-Labeled, Self-Quenched Probes
por: Huang, Qiuying, et al.
Publicado: (2011)

The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects
por: Li, Ting, et al.
Publicado: (2022)

Impact of immunopathology on the antituberculous activity of pyrazinamide
por: Blanc, Landry, et al.
Publicado: (2018)

Pyrazinamide may possess cardioprotective properties
por: Sinha, Sharabh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ckhl205egink8gok1dueegmv3g